If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Schedule 1 - Kanyon plc

13 Dec 2007 14:36

AIM13 December 2007 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") COMPANY NAME: Kanyon Plc (to be renamed Oxford Advanced Surfaces Group Plc) COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :REGISTERED ADDRESS: 17 Hanover Square, London W1S 1HU PROPOSED PRINCIPAL PLACE OF BUSINESS ON ADMISSION: Begbroke Centre for Innovation and EnterpriseOxford University Begbroke Science ParkSandy Lane, YarntonUnited KingdomOX5 1PF COUNTRY OF INCORPORATION: England and Wales COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26: http://www.oxfordadvancedsurfaces.com COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITSINVESTING STRATEGY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BESTATED: Under the AIM Rules the transaction is classified as a reverse takeover of Oxford Advanced Surfaces Limited byKanyon Plc. The Ordinary Shares of Kanyon Plc were admitted to AIM on 10 October 2006. At the same time, Kanyon Plc outlineda strategy of investing in, or acquiring assets, businesses or companies in the energy and resources sectors. Oxford Advanced Surfaces Limited is engaged in the development and commercialisation of technology which enablesthe modification of the surface properties of a broad range of materials. The Technology is based on research that commenced over ten years ago at the Department of Chemistry at theUniversity of Oxford which has led to the platform of intellectual property rights which, together with furtherknow-how developed since this time, comprise the Technology. The Technology is capable of being applied tomodify the surface properties of materials such as natural and synthetic polymers, as well as inorganic surfacessuch as glass and diamonds. Initial applications for the Technology include colouration, adhesion, bio-activityand tailored wetting properties. Oxford Advanced Surfaces Limited is a trading company whose main country of operation is the UK. DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. whereknown, number and type of shares, nominal value and issue price to which it seeks admission and the number andtype to be held as treasury shares): 177,924,038 ordinary shares of £0.01 each CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:Capital to be Raised: £3,000,000 (before expenses) Market capitalisation: approximately £44.5 million at a subscription price of 25p PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION: 77.83% DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THECOMPANY) ARE OR WILL BE ADMITTED OR TRADED: N/A FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is knownor including any other name by which each is known): David Robert Norwood (Non-Executive Chairman) (who will become Non-Executive Director on Admission)Michael Anthony Bretherton (Finance Director)Byron David Lloyd (Non-Executive Director) (who will resign on Admission)Alan John Aubrey (Non-Executive Director) (who will resign on Admission)Matthew Leslie Sutcliffe (Non-Executive Director) (who will resign on Admission)Jeremy Paul Scudamore (Proposed Non-Executive Chairman)Marcelo Leonardo Bravo Cordero (Proposed Chief Executive Officer)Dr Mark Gerard Moloney (Proposed Non-Executive Director)Dr Andrew James Naylor (Proposed Non-Executive Director) FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFOREAND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which eachis known): Shareholder % Before % After Admission AdmissionOra Capital Partners Plc 42.94 28.07Richard Griffiths 11.40 5.66Dolven Holdings Limited 11.31 5.62David Norwood 10.27 5.10Barnard Nominees Limited* 10.21 5.07Bainunah Trading Limited ** 6.79 3.37Stephen James 3.39 1.69IP2IPO Limited 15.73IP2IPO Nominees Limited 3.34The Chancellor, Masters and Scholars of 9.70the University of OxfordMark Moloney 5.69Jon-Paul Griffiths 5.69Marcelo Bravo 3.03 *Held on behalf of Elenora International Investment Limited in which Robert Quested has an interest. ** Beneficial owner is Elenora Trust, in which Robert Quested has an interest NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:N/A (i) ANTICIPATED ACCOUNTING REFERENCE DATE(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED(iii)DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:(i) 31 January(ii) 31 July 2007(iii)31 July 2008; 31 October 2008; 31 July 2009 EXPECTED ADMISSION DATE: 31 December 2007 NAME AND ADDRESS OF NOMINATED ADVISER: Zimmerman Adams International LimitedNew Broad Street House35 New Broad StreetLondon EC2M 1NH NAME AND ADDRESS OF BROKER: Hichens, Harrison & Co. plcBell Court House11 Blomfield StreetLondon EC2M 1LB OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSIONDOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THEADMISSION OF ITS SECURITIES: Zimmerman Adams International LimitedNew Broad Street House35 New Broad StreetLondon EC2M 1NH DATE OF NOTIFICATION: 13 December 2007 NEW/ UPDATE: New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.